SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDp Poland Regulatory News (DPP)

Share Price Information for Dp Poland (DPP)

Share Price is delayed by 15 minutes
Get Live Data
7.50    0.00 (0.00%)
Bid:
7.00
Ask:
8.00
Spread: 1.00 (14.286%)
Market Cap: £70.80m
DPP Live PriceLast checked at - London Stock Exchange

Intraday Dp Poland Share Chart

Possible Transaction and Suspension

6 Aug 2020 07:00

RNS Number : 2909V
DP Poland PLC
06 August 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 ("MAR"). 

 

 

6 August 2020

 

DP Poland plc

 

("DP Poland" or the "Company")

 

Possible Transaction and Suspension

 

DP Poland is pleased to announce that an application with the Polish Competition Authority will be filed today, and subsequently a notification that the application has been made will be published on the Polish Competition Authority's website, in respect of the possible acquisition (the "Acquisition") of the entire issued (and to be issued) share capital Dominium S.A. ("Dominium"), a Polish pizza restaurant group. As a result of the Acquisition, it is anticipated that Dominium's largest shareholder, Accession Mezzanine Capital III L.P., will acquire direct or indirect majority control of the Company's shares.

 

The Company has entered into a non-binding letter of intent to enter into advanced discussions with Dominium regarding the potential Acquisition. In addition to the competition authority approval, the proposed Acquisition is subject to, inter alia, due diligence, the execution of a share purchase agreement, the publication of an admission document by the Company and all necessary shareholder and regulatory approvals.

 

If completed, the Acquisition is expected to constitute a reverse takeover of the Company under AIM Rule 14.

 

Accordingly, the Company's shares have today been suspended pursuant to AIM Rule 40.

 

The Company's shares will remain suspended until such time as the Company publishes an admission document or discussions in relation to the possible reverse takeover transaction cease.

 

Shareholders are advised that there can be no certainty that the discussions between the parties will lead to any agreement concerning the possible transaction or as to the timing or terms of any such transaction and there can be no assurance that, even if agreement is reached, any such transaction would be completed.

 

The Directors believe the potential Acquisition will create a superior restaurant group with greater scale and to utilise the anticipated synergies which are expected to be presented upon a combination of both businesses under the Domino's brand.

 

Further announcements will be made in due course.

 

The person responsible for arranging the release of this announcement on behalf of the Company is Nick Donaldson, Non-Executive Chairman.

 

 

Enquiries to:

 

DP Poland PLC

Nick Donaldson, Non-Executive Chairman

Iwona Olbryś, CEO

 

Tel: +44 (0) 20 3393 6954

 

N+1 Singer (Nominated Adviser and Broker to Dream)

Shaun Dobson / George Tzimas / Amanda Gray

 

Tel: +44 (0) 20 7496 3000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUPUUCRUPUGBA
Date   Source Headline
29th May 202612:00 pmRNS2025 Annual Report and Notice of 2026 AGM
28th May 20267:00 amRNSFinal Results 2025 and Investor Presentation
14th Apr 20267:00 amRNSQ1 2026 Trading Update
12th Mar 20267:00 amRNS-RYellowstone Advisory Private Investor Evening
9th Mar 20267:00 amRNSAppointment of Non-Executive Director
5th Feb 20267:00 amRNSBoard Changes
14th Jan 20267:00 amRNSFull Year Trading Update
27th Nov 20257:00 amRNSNew Financing Arrangements
20th Oct 20257:00 amRNSRenewal of Master Franchise Agreement
14th Oct 20257:00 amRNSQ3 2025 Trading Update
15th Sep 20257:00 amRNSInterim Results and Trading Update
12th Sep 20257:00 amRNSNotice of Results & Investor Presentation
24th Jul 20254:26 pmRNSResult of AGM
10th Jul 20257:00 amRNSTrading Update
30th Jun 202510:04 amRNS2024 Annual Report and Notice of AGM
27th Jun 20257:00 amRNSFinal Results 2024 and Investor Presentation
23rd May 20254:01 pmRNSTiming of Final Results
16th Apr 20257:00 amRNSTrading Update
10th Apr 202512:15 pmRNSHolding(s) in Company
1st Apr 20257:00 amRNSChange of Registered Office
27th Mar 20257:00 amRNSStrategic Acquisition
28th Feb 202512:15 pmRNSExercise of Options & TVR
16th Jan 20257:00 amRNSFull Year unaudited Trading Update for 2024
4th Nov 20247:00 amRNSTrading Update
4th Oct 202410:00 amRNSDirector/PDMR Dealing
17th Sep 20247:00 amRNSInterim Results & Trading Update
30th Aug 20247:00 amRNSNotice of Results and Investor Presentation
11th Jul 20247:00 amRNSTrading Update
27th Jun 20241:07 pmRNSResult of AGM
3rd Jun 20248:42 amRNSPosting of Annual Report & Notice of AGM
31st May 20247:00 amRNSFinal Results
20th May 20248:56 amRNSGrant of Options (Replacement)
29th Apr 202412:30 pmRNSGrant of Options
29th Apr 20247:00 amRNSTrading Update
25th Apr 20244:50 pmRNSExercise of Options & TVR
19th Apr 20241:21 pmRNSHolding(s) in Company
19th Apr 20249:57 amRNSDirector/PDMR Dealing
18th Apr 20241:40 pmRNSResult of General Meeting
16th Apr 20247:00 amRNSResult of Retail Offer
3rd Apr 20247:00 amRNSPublication of Circular
28th Mar 20244:01 pmRNSLaunch of Retail Offer
28th Mar 20244:00 pmRNSResult of Placing
28th Mar 202411:05 amRNSClose of Bookbuild
27th Mar 20244:45 pmRNSProposed Fundraise
16th Jan 20247:00 amRNSTrading Update
15th Nov 20237:00 amRNSBoard Changes
14th Nov 20237:00 amRNSTrading Update
10th Oct 20237:00 amRNSBoard Changes
26th Sep 20237:00 amRNSInterim Results & Trading Update
22nd Sep 20237:00 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.